Kolexia
Flourie Bernard Gastro-entérologie
Flourie Bernard
Gastro-entérologie
Hôpital Lyon Sud
Pierre-Bénite, France
133 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Crohn Maladies inflammatoires intestinales Rectocolite hémorragique Colite Nécrose Ulcère Fistule Tumeurs du côlon Inflammation

Collaborateurs

Voir plus
Nancey Stephane
Nancey Stephane
Hôpital Lyon Sud, Pierre-Bénite, France
Boschetti Gilles
Boschetti Gilles
Hôpital Lyon Sud, Pierre-Bénite, France
Roblin Xavier
Roblin Xavier
Hôpital Nord CHU Saint-Étienne - Loire, Saint-Priest-en-Jarez, France
Moussata Driffa
Moussata Driffa
Hôpital Trousseau Chambray lès Tours, Chambray-lès-Tours, France

Industries

Voir plus
IQVIA
98 collaboration(s)
Dernière en 2023
A+A
31 collaboration(s)
Dernière en 2022
Zeste Research
8 collaboration(s)
Dernière en 2021
WorldOne
8 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
CYTOVEDO: Impact of Anti-cytomegalovirus (Valganciclovir) Treatment in the Management of Relapsing Ulcerative Colitis (UC) Requiring Vedolizumab Therapy: a Randomized Clinical Trial Comparing a Strategy With or Without Antiviral Therapy.
Essai Clinique (CHU Saint-Étienne)   06 juin 2023
RECOHFERRON: Place of the QuantiFERON-CMV (QF-CMV) Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis (UC)
Essai Clinique (CHU Saint-Étienne)   14 avril 2023
P144 Impact of major medication discontinuation during the first wave of COVID-19 pandemic on the risk of early relapse in patients with inflammatory bowel disease: a French observational retrospective study
Abstracts of the 18th Congress of ECCO Copenhagen, Denmark, March 1-4, 2023   30 janvier 2023
IPEC: Exocrine Pancreatic Insufficiency's Prevalence in Active Crohn's Disease Treated by Biological Therapy
Essai Clinique (Hospices Civils de Lyon)   02 janvier 2023
Relationships of circulating CD4 T cell subsets and cytokines with the risk of relapse in patients with Crohn's disease.
Frontiers in immunology   04 novembre 2022
Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug Levels.
Inflammatory bowel diseases   09 mai 2022
Subcutaneous injection of infliximab CT-P13 results in stable drug levels within 14-day treatment cycle in Crohn's disease.
Alimentary pharmacology & therapeutics   28 février 2022
Intestinal Conventional Ultrasonography, Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography in Assessment of Crohn's Disease Activity: A Comparison with Surgical Histopathology Analysis.
Digestive diseases and sciences   30 mai 2021
Spécificité des stratégies de coping des patients en rémission de la maladie de Crohn : une étude qualitative
Pratiques Psychologiques   27 mai 2021
Comparison of short- and long-term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti-tumour necrosis factor therapy.
Alimentary pharmacology & therapeutics   28 avril 2021